| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,811 |
4,298 |
$619K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,696 |
5,217 |
$529K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
819 |
806 |
$99K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,832 |
1,796 |
$82K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
561 |
553 |
$66K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
374 |
355 |
$49K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
410 |
393 |
$43K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
297 |
296 |
$40K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,279 |
1,233 |
$26K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
265 |
258 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
228 |
203 |
$20K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,655 |
1,513 |
$19K |
| 92551 |
|
1,719 |
1,667 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
565 |
467 |
$16K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
630 |
606 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
906 |
858 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
161 |
142 |
$7K |
| 96127 |
|
1,000 |
753 |
$7K |
| 99072 |
|
1,076 |
1,014 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
58 |
53 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
134 |
67 |
$2K |
| 99172 |
|
180 |
168 |
$2K |
| 85018 |
|
756 |
738 |
$2K |
| 80061 |
Lipid panel |
129 |
120 |
$2K |
| 0002A |
|
36 |
36 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
71 |
68 |
$1K |
| 83655 |
|
68 |
68 |
$945.60 |
| 0001A |
|
36 |
36 |
$900.00 |
| 81003 |
|
373 |
352 |
$864.84 |
| 90480 |
|
21 |
21 |
$840.00 |
| 0053A |
|
13 |
13 |
$520.00 |
| 0071A |
|
19 |
19 |
$475.00 |
| 87807 |
|
18 |
18 |
$266.40 |
| 90473 |
|
12 |
12 |
$248.16 |
| 90474 |
|
12 |
12 |
$165.96 |
| 90620 |
|
12 |
12 |
$165.75 |
| 90686 |
|
1,425 |
1,403 |
$147.56 |
| 90656 |
|
79 |
79 |
$18.98 |
| 91300 |
|
88 |
80 |
$0.88 |
| 91307 |
|
19 |
19 |
$0.19 |
| 91305 |
|
16 |
16 |
$0.16 |
| 91321 |
|
13 |
13 |
$0.13 |
| 90670 |
|
265 |
263 |
$0.00 |
| 99177 |
|
1,196 |
1,174 |
$0.00 |
| 90734 |
|
66 |
66 |
$0.00 |
| 90633 |
|
75 |
75 |
$0.00 |
| 90715 |
|
30 |
30 |
$0.00 |
| 90710 |
|
16 |
16 |
$0.00 |
| 90723 |
|
93 |
93 |
$0.00 |
| 90647 |
|
115 |
115 |
$0.00 |
| 90680 |
|
38 |
38 |
$0.00 |
| 90651 |
|
85 |
84 |
$0.00 |
| 90696 |
|
13 |
13 |
$0.00 |